Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3.
After fixation in the human genome, human endogenous retroviruses (HERVs) are bona fide cellular genes despite their exogenous origin. To be able to spread within the germ line and the early embryo, the ancient retroviral promoters must have adapted to the requirements for expression in these cell types. We describe that in contrast to the case for current exogenous retroviruses, which replicate in specific somatic cells, the long terminal repeat (LTR) of the human endogenous retrovirus HERV-K acts as a TATA- and initiator element-independent promoter with a variable transcription start site. We present evidence that the HERV-K LTR is regulated by the transcription factors Sp1 and Sp3. Mutating specific GC boxes, which are binding sites for Sp proteins, and knocking down Sp1 and Sp3 by use of small interfering RNA (siRNA) significantly reduced the promoter activity. Binding of Sp1 and Sp3 to the promoter region was confirmed using electrophoretic mobility shift assays (EMSAs) and chromatin immunoprecipitation (ChIP). Our data explain why certain HERV-K proviruses have lost promoter competence. Since vertebrate promoters lacking canonical core promoter elements are common but poorly studied, understanding the HERV-K promoter not only will provide insight into the regulation of endogenous retroviruses but also can serve as a paradigm for understanding the regulation of this class of cellular genes.
Paul Ehrlich Institut, Federal Institute for Vaccines and Biomedicines, Paul-Ehrlich-Strasse 51-59, D-63225 Langen, Germany.
Nina V
NV
Fuchs
Martin
M
Kraft
Christiane
C
Tondera
Kay-Martin
KM
Hanschmann
Johannes
J
Löwer
Roswitha
R
Löwer
D004279:DNA, Viral / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D020077:Endogenous Retroviruses / Q000235:genetics*; D054884:Host-Pathogen Interactions; D006801:Humans; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D016329:Sp1 Transcription Factor / Q000378:metabolism*; D051705:Sp3 Transcription Factor / Q000378:metabolism*; D020079:Terminal Repeat Sequences; D024363:Transcription Initiation Site; D014158:Transcription, Genetic
D004279:DNA, Viral; C497121:SP3 protein, human; D016329:Sp1 Transcription Factor; D051705:Sp3 Transcription Factor
Nature. 1994 Sep 29;371(6496):435-8
8090226
Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14572-9
15310846
J Virol. 2005 Jan;79(2):876-83
15613316
Biochim Biophys Acta. 1997 Mar 20;1351(1-2):73-88
9116046
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4480-4
8506289
Virology. 1993 Sep;196(1):349-53
8356806
Gene. 2005 May 23;351:51-9
15857802
Genome Biol. 2010;11(3):R33
20230619
J Virol. 2005 Nov;79(22):13865-74
16254322
Genome Res. 2006 Dec;16(12):1548-56
17077319
J Mol Evol. 2001 Sep;53(3):237-43
11523010
BMC Genomics. 2008 Jul 29;9:354
18664271
EMBO J. 2003 Mar 17;22(6):1347-58
12628927
Biochem J. 2004 Jun 15;380(Pt 3):705-13
15015937
Genes Dev. 1994 Oct 1;8(19):2282-92
7958895
J Virol. 2008 Sep;82(17):8762-70
18562521
Nucleic Acids Res. 2007;35(14):4743-54
17617638
Nucleic Acids Res. 1992 Aug 25;20(16):4129-36
1508707
Mol Cell Biol. 1997 Jul;17(7):3723-32
9199306
Mol Cell Biol. 2009 May;29(9):2456-68
19273603
Mol Biol Evol. 2009 Nov;26(11):2617-26
19666991
J Biol Chem. 2001 Jun 22;276(25):22126-32
11294852
J Virol. 1996 Jan;70(1):188-98
8523525
Retrovirology. 2008 Aug 14;5:75
18702815
Cell. 1989 Apr 7;57(1):103-13
2467742
Int J Cancer. 2010 Jan 15;126(2):306-14
19795446
Mol Cell Biol. 1994 Jan;14(1):116-27
8264580
J Virol. 1999 Nov;73(11):9496-507
10516058
J Virol. 2008 Oct;82(20):10008-16
18684837
J Gen Virol. 2010 Jun;91(Pt 6):1494-502
20147518
Nature. 2004 Sep 2;431(7004):96-9
15318244
Ann Anat. 2010 Sep 20;192(5):275-83
20810260
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1412-7
16432200
Curr Opin Cell Biol. 2008 Jun;20(3):253-9
18436437
Cytogenet Genome Res. 2005;110(1-4):342-52
16093686
Nature. 2010 Apr 8;464(7290):927-31
20164836
Cytogenet Genome Res. 2005;110(1-4):353-64
16093687
Epigenetics. 2010 Jan 1;5(1):68-79
20083901
Exp Cell Res. 2009 Mar 10;315(5):849-62
19167380
J Virol. 1999 Feb;73(2):1254-61
9882329
Cytogenet Genome Res. 2005;110(1-4):318-32
16093684
Virology. 2006 Mar 15;346(2):373-8
16337666
Oncogene. 2007 Jun 21;26(29):4226-33
17237820
J Virol. 1986 Jun;58(3):937-44
3009897
J Virol. 1995 Jan;69(1):141-9
7983704
Genes Chromosomes Cancer. 2010 May;49(5):401-11
20095041
Int J Cancer. 2004 Jun 20;110(3):459-61
15095315
AIDS Res Hum Retroviruses. 2008 May;24(5):717-23
18462078
J Virol. 2001 Nov;75(21):10359-71
11581404
EMBO J. 1996 Feb 1;15(3):562-8
8599939
Nat Genet. 1998 Oct;20(2):116-7
9771701
Curr Biol. 1999 Aug 26;9(16):861-8
10469592
Cytogenet Cell Genet. 1997;78(1):1-5
9345895
J Gen Virol. 1996 Dec;77 ( Pt 12):2983-90
9000088
Mol Cell Biol. 1994 Feb;14(2):1026-38
8289783
Cytogenet Cell Genet. 1997;79(1-2):157-61
9533039
FEBS Lett. 2000 Apr 28;472(2-3):191-5
10788609
Cancer Res. 2006 Feb 1;66(3):1658-63
16452225
Cell. 1991 Feb 22;64(4):727-37
1671761
Cell Mol Life Sci. 2008 Nov;65(21):3366-82
18818873
J Virol. 1995 Jan;69(1):414-21
7983737
EMBO J. 1994 Jan 15;13(2):380-90
8313883
Genome Biol. 2010;11(6):R69
20584328